Supplementary Material for: The Use of Automated Insulin Delivery Around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)
Version 3 2024-12-09, 08:27
Version 2 2024-12-09, 08:27
Version 1 2024-10-25, 13:25
dataset
posted on 2024-12-09, 08:27 authored by Moser O., Zaharieva D., Adolfsson P., Battelino T., Bracken R., Buckingham B., Danne T., Davis E., Dovc K., Forlenza G., Gillard P., Hofer S., Hovorka R., Jacobs P., Mader J., Mathieu C., Nørgaard K., Oliver N., O’Neal D., Pemberton J., Rabasa-Lhoret R., Sherr J., Sourij H., Tauschmann M., Yardley J., Riddell M.Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes (T1D). In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with T1D to achieve the recommended glucose target ranges. PA provide additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information to develop a position statement on the topic. This joint EASD ISPAD position statement reviews current evidence on AID systems and offers detailed clinical practice points for managing PA in children, adolescents, and adults with T1D using AID technology. It discusses each available AID system individually and provides guidance on their use for PA. Additionally, it addresses different glucose responses to PA and offers stratified therapy options to maintain glycaemia within the target range for these age groups.
